Market Value108,192,580
Total Holdings60
File Date2025-06-30
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Note this is an amended filing that contain additional holdings that were omitted from a previous filing. This is not likely to be an accurate picture of the total holdings of this firm.

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
DCGO / DocGo Inc.
APLS / Apellis Pharmaceuticals, Inc.
XOM / Exxon Mobil Corporation
ATEC / Alphatec Holdings, Inc.
NBIX / Neurocrine Biosciences, Inc.
CSTL / Castle Biosciences, Inc.
BLUE / bluebird bio, Inc.
CERO THERAPEUTICS HOLDINGS INC / CLASS A COM (71902K105)
KPTI / Karyopharm Therapeutics Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
OM / Outset Medical, Inc.
QDEL / QuidelOrtho Corporation
ZNTL / Zentalis Pharmaceuticals, Inc.
BDSX / Biodesix, Inc.
AXDX / Accelerate Diagnostics, Inc.
TVTX / Travere Therapeutics, Inc.
HALO / Halozyme Therapeutics, Inc.
PHR / Phreesia, Inc.
KALV / KalVista Pharmaceuticals, Inc.
CGEM / Cullinan Therapeutics, Inc.
TXG / 10x Genomics, Inc.
AXGN / Axogen, Inc.
UTHR / United Therapeutics Corporation
PRTA / Prothena Corporation plc
IFRX / InflaRx N.V.
PTGX / Protagonist Therapeutics, Inc.
ALKS / Alkermes plc
GOSS / Gossamer Bio, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
VTYX / Ventyx Biosciences, Inc.
CORT / Corcept Therapeutics Incorporated
BMY / Bristol-Myers Squibb Company
HROW / Harrow, Inc.
XNCR / Xencor, Inc.
FHTX / Foghorn Therapeutics Inc.
SILK / Silk Road Medical, Inc
CABA / Cabaletta Bio, Inc.
ETRN / Equitrans Midstream Corporation
PGNY / Progyny, Inc.
GTHX / G1 Therapeutics, Inc.
LQDA / Liquidia Corporation
NVCR / NovoCure Limited
SRPT / Sarepta Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
TSVT / 2seventy bio, Inc.
INBX / Inhibrx Biosciences, Inc.
WVE / Wave Life Sciences Ltd.
AXSM / Axsome Therapeutics, Inc.
ELUT / Elutia Inc.
KROS / Keros Therapeutics, Inc.
OVV / Ovintiv Inc.
SWTX / SpringWorks Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
BHVN / Biohaven Ltd.
ARVN / Arvinas, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
CYTK / Cytokinetics, Incorporated
STOK / Stoke Therapeutics, Inc.
MASI / Masimo Corporation
FOLD / Amicus Therapeutics, Inc.